| Q39884644 | "On the spot" interventions by mental health nurses in inpatient psychiatric wards in Greece |
| Q37863093 | Antipsychotic polypharmacy in schizophrenia: benefits and risks |
| Q50707842 | Excessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia. |
| Q51899617 | Exploration of therapeutic interventions that accompany the administration of p.r.n. ('as required') psychotropic medication within acute mental health settings: a retrospective study. |
| Q37722004 | Medication errors in psychiatry: a comprehensive review |
| Q36438829 | PRN sedation-patterns of prescribing and administration in a child and adolescent mental health inpatient service. |
| Q34030201 | Pro Re Nata Prescription and Perception Difference between Doctors and Nurses |
| Q51888645 | Pro re nata medication for psychiatric inpatients: time to act. |
| Q38240053 | Pro re nata prescribing in a population receiving palliative care: a prospective consecutive case note review |
| Q50802748 | Pro re nata use in a psychiatric intensive care unit. |
| Q80765764 | Psychiatric use of unscheduled medications in the Pennsylvania state hospital system: effects of discontinuing the use of P.R.N. orders |
| Q51942639 | Psychotropic PRN: a model for best practice management of acute psychotic behavioural disturbance in inpatient psychiatric settings. |
| Q35044176 | Reducing the rates of prescribing high-dose antipsychotics and polypharmacy on psychiatric inpatient and intensive care units: results of a 6-year quality improvement programme |
| Q45904922 | The use and effectiveness of pro re nata psychotropic medications in children and adolescents: A systematic review. |
| Q51935662 | The use and nursing management of benzodiazepines in acute, mental health inpatient care: a discussion. |
| Q46710247 | Use of pro re nata medications in acute inpatient care. |